Wed Oct 02 13:18:50 UTC 2024: ## Truist Boosts Teva Pharmaceutical Holdings Amid Positive Analyst Sentiment

**New York, NY** – Truist Financial Corp increased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 7% in the second quarter, according to HoldingsChannel. The firm now owns over 3.8 million shares, valued at $63.1 million. This move follows a trend of several institutional investors adjusting their positions in Teva, including Norges Bank and TD Asset Management Inc.

Teva reported strong second-quarter earnings on July 31st, exceeding analyst expectations and showcasing a positive return on equity. The company’s revenue also surpassed forecasts, further solidifying its strong performance.

Positive analyst sentiment surrounding Teva continues to grow, with Jefferies Financial Group, UBS Group, and Barclays all raising their price targets for the stock.

“Teva is demonstrating strong financial performance, and the positive analyst sentiment reflects this,” stated a MarketBeat spokesperson. “The company’s focus on generic medicines and specialty products, coupled with its recent earnings beat, has boosted investor confidence.”

While Truist’s increased stake in Teva is encouraging, it’s important to note that insider Eric A. Hughes sold a significant portion of his shares in August. This transaction may signal a more cautious approach from some insiders.

Overall, Teva Pharmaceutical Industries remains a popular choice for investors, with a consensus “Moderate Buy” rating and a consensus target price of $18.89.

**To learn more about Teva Pharmaceutical Industries and other companies, visit HoldingsChannel.com.**

Read More